Rad AI raised its Series C funding to $68 million, with $8 million from top U.S. health systems.
Key Details
- 1Advocate Health, Memorial Hermann, Corewell Health, and Atlantic Health System invested a combined $8 million.
- 2The total fundraising for Rad AI's Series C is $68 million.
- 3Rad AI's solutions reportedly impact nearly half of all imaging volumes in the U.S.
- 4The company achieved 8,710% revenue growth from 2020-2023.
- 5Rad AI is valued at $525 million according to Pitchbook estimates.
- 6The investment aims to drive systemwide adoption of radiology AI and address clinical and operational pressures.
Why It Matters
Such large-scale investment by major health systems signals growing confidence in radiology-focused AI solutions and supports further innovation and adoption. This collaboration could accelerate AI integration across the imaging workflow, with potential improvements in patient care and operational efficiency.
Source
Radiology Business
Related News
•Radiology Business
Harrison.ai Receives FDA Breakthrough Status for Imaging AI Device
Harrison.ai has been awarded three FDA breakthrough device designations for its imaging AI solutions, including a tool for obstructive hydrocephalus triage.
•AuntMinnie
Experts Call for Stricter FDA Standards in Radiology AI Validation
Dana-Farber experts recommend actionable steps to enhance the rigor and transparency of FDA validation standards for radiology AI software.
•Cardiovascular Business
FDA Authorizes AI Tool for Detecting Mitral Annular Calcification on Routine CT
Bunkerhill Health receives FDA clearance for an AI model that detects mitral annular calcification (MAC) on routine, non-gated CT scans.